| abstract |
The present invention relates to a novel CRS fragment peptide having immune enhancing activity and uses thereof, and more particularly, to a novel peptide consisting of the amino acid sequence of SEQ ID NO: 2, a vaccine adjuvant thereof, and use as a therapeutic agent for cancer. The peptide disclosed in the present invention is a CRS fragment disclosed for the first time in the present specification, and exhibits anticancer activity and immune function enhancing activity. In addition, the peptide, the polynucleotide encoding the same, the vector containing the polynucleotide, the host cell transformed with the vector, or the full-length CRS protein are excellent in anticancer activity and immune function enhancing activity, so vaccine adjuvant, vaccine composition and cancer It can be very usefully utilized in the development of a therapeutic composition. |